Abstract:Background: In this study, we examined the length of stay (LoS)-predictive comorbidities, hospital costs-predictive comorbidities, and mortality-predictive comorbidities in immobile ischemic stroke (IS) patients; second, we used the Charlson Comorbidity Index (CCI) to assess the association between comorbidity and the LoS and hospitalization costs of stroke; third, we assessed the magnitude of excess IS mortality related to comorbidities. Methods: Between November 2015 and July 2017, 5114 patients hospitalized for IS in 25 general hospitals from six provinces in eastern, western, and central China were evaluated. LoS was the period from the date of admission to the date of discharge or date of death. Costs were collected from the hospital information system (HIS) after the enrolled patients were discharged or died in hospital. The HIS belongs to the hospital's financial system, which records all the expenses of the patient during the hospital stay. Cause of death was recorded in the HIS for 90 days after admission regardless of whether death occurred before or after discharge. Using the CCI, a comorbidity index was categorized as zero, one, two, and three or more CCI diseases. A generalized linear model with a gamma distribution and a log link was used to assess the association of LoS and hospital costs with the comorbidity index. Kaplan-Meier survival curves was used to examine overall survival rates. Results: We found that 55.2% of IS patients had a comorbidity. Prevalence of peripheral vascular disease (21.7%) and diabetes without end-organ damage (18.8%) were the major comorbidities. A high CCI=3+ score was an effective predictor of a high risk of longer LoS and death compared with a low CCI score; and CCI=2 score and CCI=3+ score were efficient predictors of a high risk of elevated hospital costs. Specifically, the most notable LoS-specific comorbidities, and cost-specific comorbidities was dementia, while the most notable mortality-specific comorbidities was moderate or severe renal disease. Conclusion: CCI has significant predictive value for clinical outcomes in IS. Due to population aging, the CCI should be used to identify, monitor and manage chronic comorbidities among immobile IS populations. Copyright: (c) 2021 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/ by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Liu H, Song B, Jin J, et al. Length of stay, hospital costs and mortality associated with comorbidity according to the Charlson comorbidity index in immobile patients after ischemic stroke in China: a national study. Int J Health

Impact of Charlson Comorbidity Index on in‐hospital mortality of patients with hyperglycemic crises: A propensity score matching analysis

Length of Stay, Hospital Costs and Mortality Associated with Comorbidity According to the Charlson Comorbidity Index in Immobile Patients after Ischemic Stroke in China: A National Study.

Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay and Mortality among Immobile Hemorrhagic Stroke Patients Younger Than 50 Years

The Impact of Diabetes on Mortality in Inpatients from Medical Department of A Chinese Tertiary Hospital

Impact of the Charlson Comorbidity Index on Delirium Outcomes

Prognostic value of Charlson Comorbidity Index for acute coronary syndrome

Charlson Comorbidity Index Helps Predict the Risk of Mortality for Patients with Type 2 Diabetic Nephropathy.

The Impact of Blood Glucose Level on the Clinical Outcomes of Patients Hospitalized with Community-Acquired Pneumonia: A Multicenter, Retrospective Study

Stress-induced Hyperglycemia Ratio As an Independent Risk Factor of In-hospital Mortality in Nonresuscitation Intensive Care Units: A Retrospective Study.

Feasibility of coding-based Charlson comorbidity index for hospitalized patients in China, a representative developing country

Charlson Comorbidity Index: A Critical Review of Clinimetric Properties

Comparison of Charlson's Weighted Index of Comorbidities with the Chronic Health Score for the Prediction of Mortality in Septic Patients.

Relationship between stress hyperglycemia ratio and allcause mortality in critically ill patients: Results from the MIMIC-IV database

Stress hyperglycemia ratio linked to worse prognosis in Cardiac Intensive Care Unit patients: A retrospective observational study

The Association Between Hemoglobin A1c and All-Cause Mortality in the ICU: A Cross-Section Study Based on MIMIC-IV 2.0.

Clinical Validation of the Comprehensive Complication Index in a Pancreaticoduodenectomy Cohort.

Clinical Analysis of Inpatients with Hyperglycemia in the Medical Intensive Care Units——data of Shanghai Renji Hospital from 2002 to 2009

Comorbidity profiles and pulmonary embolism risk assessment: Leveraging the Charlson Comorbidity Index for improved prognostication in a national data set

Association of cardiovascular-kidney-metabolic index with all-cause mortality during hospitalization in critically ill patients: a retrospective cohort study from MIMIC IV2.2

Association between the triglyceride glucose index and length of hospital stay in patients with heart failure and type 2 diabetes in the intensive care unit: a retrospective cohort study

Relationship Between Hyperglycaemia at Admission and Prognosis in Patients with Acute Myocardial Infarction: a Retrospective Cohort Study